EFMH
IONS icon

E Fund Management (HK)’s Ionis Pharmaceuticals IONS Stock Holding History

E Fund Management (HK)’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.6K Buy
260
+65
+33% +$4.89K 0.01% 310
2026
Q1 		$14.6K Buy
+195
New +$15.4K 0.01% 264

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

E Fund Management (HK)'s IONS Position: Q2 2026 in Review

E Fund Management (HK) increased its Ionis Pharmaceuticals (IONS) stake by 33% in Q2 2026, buying an estimated $4.89K and bringing the position to 260 shares worth $20.6K. The position accounts for 0.01% of the portfolio, ranked #310.

E Fund Management (HK) first reported a position in IONS in Q1 2026 and has held it in 2 quarters since. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • E Fund Management (HK) held 260 shares of Ionis Pharmaceuticals worth $20.6K as of Q2 2026.
  • E Fund Management (HK) bought 65 Ionis Pharmaceuticals shares in Q2 2026, an estimated $4.89K.
  • Ionis Pharmaceuticals made up 0.01% of E Fund Management (HK)'s portfolio in Q2 2026, its #310 holding.
  • E Fund Management (HK) first reported a position in Ionis Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on E Fund Management (HK)'s 13F filing for Q2 2026, filed 22 Jul 2026.